CClinicalTrials.gg
CompletedNCT01044212Updated Oct 21, 2015Results posted

Bowel Function After Minimally Invasive Urogynecologic Surgery

An interventional study of Docusate and Bowel medications in Functional Disorder of Intestine, sponsored by University of Rochester. Completed at 1 site in United States. Open to female participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-10-21.

Sponsored by University of Rochester · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
Female
01

Study summary

The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.

Read the detailed description

See above

02

Conditions studied

  • Functional Disorder of Intestine

Browse trials for

Keywords

  • Urogynecology
03

In context

Intestinal Diseases

963 studies on the registry are indexed under Intestinal Diseases; 174 are open to participants now.

This study's enrollment of 72 is close to the median of 70 across 552 interventional studies indexed under Intestinal Diseases.

Browse Intestinal Diseases studies →

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Planning to be admitted to the hospital to undergo minimally-invasive urogynecologic surgery at Strong Memorial Hospital.

Procedures may include:

  • robot-assisted laparoscopic sacrocolpopexy
  • sacrospinous ligament suspension
  • uterosacral ligament suspension/paravaginal defect repair
  • colpocleisis
  • cystocele repair

Additional procedures may include:

  • hysterectomy
  • adnexectomy
  • culdoplasty
  • minimally invasive sling procedure (TVT or TOT)
  • periurethral collagen injections
  • enterocele repair

Exclusion criteria

Exclusion Criteria:

  • Planning to undergo laparotomy.
  • Undergoing rectocele or perineocele repair as part of surgery.
  • Taking Miralax, laxatives, enemas, or suppositories daily, at the time of enrollment.
  • Presence of a colostomy.
  • Chronic kidney disease
  • Insulin-dependent diabetes mellitus
  • Known cardiac disease
  • Gastric ulcers
  • Difficulty swallowing or esophageal stricture
  • Persistent nausea and vomiting
  • Signs and symptoms consistent with bowel obstruction
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Active comparator
    Docusate

    Docusate is the standard of care regimen

    Drug: Docusate

  • Experimental
    Bowel medications

    Docusate, Miralax, Metamucil wafers, Bisacodyl suppository

    Drug: Bowel medications

Interventions

  • DrugDocusate

    Docusate 100mg BID

    Also known as: Colace

  • DrugBowel medications

    Docusate 100mg BID Metamucil fiber wafers - 2 wafers daily Miralax 1 packet daily Bisacodyl 1 suppository BID

    Also known as: Colace, Psyllium, Polyethylene glycol, Dulcolax

06

What researchers measure

Primary outcomes

  1. Time to First Post-op Bowel Movement

    The time to first post-operative bowel movement was measured in hours after surgery.

    Time frame: Within 1 week of surgery

Secondary outcomes

  1. Pain Level Associated With First Postoperative Bowel Movement

    The pain level experienced with the first post-operative bowel movement was recorded and measured on visual analog score with range 0 to 10 in units on scale. 0 being no pain at all. 10 being worst pain.

    Time frame: Within 1 week of surgery

  2. Consistency of First Postoperative Bowel Movement

    The consistency of the first post-operative bowel movement was rated using the Bristol Stool Scale. This is a validated scale that is widely used. It is given to patients as a chart. The chart can be seen here: http://en.wikipedia.org/wiki/Bristol_stool_scale. The seven types of stool are: Type 1: Separate hard lumps, like nuts (hard to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft Type 5: Soft blobs with clear cut edges (passed easily) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces. Entirely liquid

    Time frame: Within 1 week of surgery

07

Results

Posted Oct 21, 2015

Participant flow

Candidates meeting criteria were offered participation at their preoperative visit.

Participant flow — Overall Study
MilestoneBowel MedicationsDocusate Controls
Started3537
Completed3030
Not completed57

Outcome measures

PrimaryTime to First Post-op Bowel Movement

The time to first post-operative bowel movement was measured in hours after surgery.

Time frame:
Within 1 week of surgery
Reported as:
Mean · hours
Time to First Post-op Bowel Movement
hoursBowel MedicationsDocusate Controls
Time to First Post-op Bowel Movement64 ± 2177 ± 24
SecondaryPain Level Associated With First Postoperative Bowel Movement

The pain level experienced with the first post-operative bowel movement was recorded and measured on visual analog score with range 0 to 10 in units on scale. 0 being no pain at all. 10 being worst pain.

Time frame:
Within 1 week of surgery
Reported as:
Mean · VAS pain score
Pain Level Associated With First Postoperative Bowel Movement
VAS pain scoreBowel MedicationsDocusate Controls
Pain Level Associated With First Postoperative Bowel Movement3.6 ± 3.23.7 ± 2.8
SecondaryConsistency of First Postoperative Bowel Movement

The consistency of the first post-operative bowel movement was rated using the Bristol Stool Scale. This is a validated scale that is widely used. It is given to patients as a chart. The chart can be seen here: http://en.wikipedia.org/wiki/Bristol_stool_scale. The seven types of stool are: Type 1: Separate hard lumps, like nuts (hard to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft Type 5: Soft blobs with clear cut edges (passed easily) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces. Entirely liquid

Time frame:
Within 1 week of surgery
Reported as:
Mean · Bristol Stool Scale
Consistency of First Postoperative Bowel Movement
Bristol Stool ScaleBowel MedicationsDocusate Controls
Consistency of First Postoperative Bowel Movement3.13 ± 1.223.40 ± 1.07

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Bowel Medications—0/35 (0%)0/35 (0%)
Docusate Controls—0/37 (0%)0/37 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Bowel MedicationsDocusate ControlsTotal
<=18 years000
Between 18 and 65 years192948
>=65 years16824
Age, Continuous
Age, Continuous(years)Bowel MedicationsDocusate ControlsTotal
Mean58 ± 1063 ± 961 ± 9.5
Sex: Female, Male
Sex: Female, Male(Participants)Bowel MedicationsDocusate ControlsTotal
Female353772
Male000
Region of Enrollment
Region of Enrollment(participants)Bowel MedicationsDocusate ControlsTotal
United States353772
08

Study locations

1 site
  • University of Rochester
    Rochester, New York 14642, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01044212
Lead sponsor
University of Rochester
Responsible party
Gunhilde Buchsbaum (Professor, University of Rochester) — Principal investigator
First posted
Jan 7, 2010
Start date
Nov 2009
Primary completion
Feb 2011
Completion
Feb 2011
Results posted
Oct 21, 2015
Last update
Oct 21, 2015

Study contacts

Gunhilde Buchsbaum, MD
principal investigator · University of Rochester

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion